Power Corporation of Canada (FRA:PCR)
Germany · Delayed Price · Currency is EUR 42.00
-0.40 (-0.94%)
Last updated: Jan 30, 2026, 8:24 AM CET
FRA:PCR Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Premiums & Annuity Revenue | 22,030 | 21,214 | 20,402 | 19,632 | 52,791 | 42,999 |
Total Interest & Dividend Income | 5,185 | 4,470 | 421 | 25,470 | 6,485 | 5,862 |
Gain (Loss) on Sale of Investments | 1,369 | 1,830 | 6,415 | -31,240 | -1,209 | 6,300 |
Other Revenue | 9,784 | 8,872 | 5,361 | 17,721 | 11,524 | 9,471 |
| 38,368 | 36,386 | 32,599 | 31,583 | 69,591 | 64,632 | |
Revenue Growth (YoY) | 9.88% | 11.62% | 3.22% | -54.62% | 7.67% | 32.20% |
Policy Benefits | 17,831 | 17,122 | 16,557 | 16,105 | 50,295 | 48,487 |
Policy Acquisition & Underwriting Costs | 748 | 748 | 702 | 637 | 3,910 | 3,439 |
Selling, General & Administrative | 13,589 | 12,462 | 11,103 | 9,658 | 10,076 | 7,995 |
Other Operating Expenses | 97 | 97 | 62 | 61 | - | 480 |
Total Operating Expenses | 32,256 | 30,420 | 28,415 | 26,498 | 64,311 | 60,417 |
Operating Income | 6,112 | 5,966 | 4,184 | 5,085 | 5,280 | 4,215 |
Interest Expense | -816 | -786 | -737 | -645 | -576 | -528 |
Earnings From Equity Investments | 650 | 376 | 615 | -34 | 729 | 170 |
Other Non Operating Income (Expenses) | -26 | -26 | -29 | -27 | -23 | -27 |
EBT Excluding Unusual Items | 5,920 | 5,530 | 4,033 | 4,379 | 5,410 | 3,830 |
Merger & Restructuring Charges | -172 | - | - | - | -94 | -219 |
Asset Writedown | - | - | -111 | -25 | - | - |
Pretax Income | 5,748 | 5,530 | 3,922 | 4,354 | 5,316 | 3,611 |
Income Tax Expense | 811 | 929 | 263 | 646 | 643 | 77 |
Earnings From Continuing Ops. | 4,937 | 4,601 | 3,659 | 3,708 | 4,673 | 3,534 |
Earnings From Discontinued Ops. | - | -71 | -124 | -32 | - | - |
Net Income to Company | 4,937 | 4,530 | 3,535 | 3,676 | 4,673 | 3,534 |
Minority Interest in Earnings | -1,788 | -1,735 | -1,288 | -1,429 | -1,704 | -1,488 |
Net Income | 3,149 | 2,795 | 2,247 | 2,247 | 2,969 | 2,046 |
Preferred Dividends & Other Adjustments | 52 | 52 | 52 | 52 | 52 | 52 |
Net Income to Common | 3,097 | 2,743 | 2,195 | 2,195 | 2,917 | 1,994 |
Net Income Growth | 38.84% | 24.39% | - | -24.32% | 45.11% | 76.38% |
Shares Outstanding (Basic) | 643 | 648 | 662 | 671 | 677 | 648 |
Shares Outstanding (Diluted) | 649 | 652 | 663 | 674 | 682 | 648 |
Shares Change (YoY) | -0.72% | -1.67% | -1.54% | -1.19% | 5.25% | 47.89% |
EPS (Basic) | 4.82 | 4.23 | 3.32 | 3.27 | 4.31 | 3.08 |
EPS (Diluted) | 4.78 | 4.19 | 3.30 | 3.22 | 4.27 | 3.08 |
EPS Growth | 43.11% | 26.87% | 2.41% | -24.49% | 38.68% | 21.72% |
Free Cash Flow | 5,408 | 5,078 | 4,637 | 3,450 | 10,487 | 9,713 |
Free Cash Flow Per Share | 8.34 | 7.79 | 6.99 | 5.12 | 15.39 | 15.00 |
Dividend Per Share | 2.350 | 2.212 | 2.070 | 1.980 | 1.790 | 1.748 |
Dividend Growth | 8.05% | 6.88% | 4.54% | 10.62% | 2.43% | 9.42% |
Operating Margin | 15.93% | 16.40% | 12.83% | 16.10% | 7.59% | 6.52% |
Profit Margin | 8.07% | 7.54% | 6.73% | 6.95% | 4.19% | 3.08% |
Free Cash Flow Margin | 14.09% | 13.96% | 14.22% | 10.92% | 15.07% | 15.03% |
EBITDA | 6,959 | 6,789 | 4,912 | 5,822 | 5,945 | 4,768 |
EBITDA Margin | 18.14% | 18.66% | 15.07% | 18.43% | 8.54% | 7.38% |
D&A For EBITDA | 847 | 823 | 728 | 737 | 665 | 553 |
EBIT | 6,112 | 5,966 | 4,184 | 5,085 | 5,280 | 4,215 |
EBIT Margin | 15.93% | 16.40% | 12.83% | 16.10% | 7.59% | 6.52% |
Effective Tax Rate | 14.11% | 16.80% | 6.71% | 14.84% | 12.10% | 2.13% |
Revenue as Reported | - | - | - | - | - | 64,616 |
Source: S&P Global Market Intelligence. Insurance template. Financial Sources.